Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    3-Carbamoyl-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 871Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Niagen Bioscience Introduces Tru Niagen Beauty
    Niagen Bioscience Introduces Tru Niagen Beauty

    13 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113779285/en/Niagen-Bioscience-Launches-Tru-Niagen-Beauty-The-First-NAD-Skincare-Supplement-in-the-U.S.-Featuring-Niagen-Patented-Nicotinamide-Riboside

    BUSINESSWIRE
    13 Nov 2025
    Share Share
    Niagen Bioscience to Report Q1 2025 Results on May 7, 2025
    Niagen Bioscience to Report Q1 2025 Results on May 7, 2025

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250425638128/en/Niagen-Bioscience-to-Report-First-Quarter-2025-Financial-Results-on-Wednesday-May-7-2025

    BUSINESSWIRE
    28 Apr 2025
    Share Share
    Niagen Gets US Patent For Nicotinamide Riboside Salt Forms
    Niagen Gets US Patent For Nicotinamide Riboside Salt Forms

    20 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250320005293/en/Niagen-Bioscience-Secures-U.S.-Patent-for-the-Composition-of-Matter-for-Nicotinamide-Riboside-NR-Salt-Forms

    BUSINESSWIRE
    20 Mar 2025
    Share Share
    Niagen® improves mobility in PAD per Phase II study.
    Niagen® improves mobility in PAD per Phase II study.

    24 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240624062781/en

    BUSINESSWIRE
    24 Jun 2024
    Share Share
    A Milestone Clinical Study Reveals that Elevating Nicotinamide Adenine Dinucleotide (NAD+) with Nicotinamide Riboside (NR) Supplementation Effectively Reduces Inflammation in Both Healthy Subjects and Immune Cells Derived from Psoriasis Patients
    A Milestone Clinical Study Reveals that Elevating Nicotinamide Adenine Dinucleotide (NAD+) with Nicotinamide Riboside (NR) Supplementation Effectively Reduces Inflammation in Both Healthy Subjects and Immune Cells Derived from Psoriasis Patients

    02 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231002427548/en

    BUSINESSWIRE
    02 Oct 2023
    Share Share
    Thorne Research, Inc. Loses Patent Challenge Decision
    Thorne Research, Inc. Loses Patent Challenge Decision

    15 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220815005235/en

    BUSINESSWIRE
    15 Aug 2022
    Share Share